Join

Compare · CDXC vs RGC

CDXC vs RGC

Side-by-side comparison of ChromaDex Corporation (CDXC) and Regencell Bioscience Holdings Limited (RGC): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both CDXC and RGC operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
  • RGC is the larger of the two at $9.88B, about 55.9x CDXC ($176.9M).
  • RGC has hit the wire 6 times in the past 4 weeks while CDXC has been quiet.
  • CDXC has more recent analyst coverage (5 ratings vs 0 for RGC).
MetricCDXCRGC
Company
ChromaDex Corporation
Regencell Bioscience Holdings Limited
Price
$7.87-0.76%
$20.09-9.50%
Market cap
$176.9M
$9.88B
1M return
-
-27.34%
1Y return
-
+25.09%
Industry
Medicinal Chemicals and Botanical Products
Medicinal Chemicals and Botanical Products
Exchange
NASDAQ
NASDAQ
IPO
2021
News (4w)
0
6
Recent ratings
5
0
CDXC

ChromaDex Corporation

ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and IMMULINA, a Braun-type lipoproteins, including spirulina extracts and active compounds, which are used to support human immune function. It also offers analytical reference standards and services comprising supply of products to conduct quality control of raw materials and consumer products in dietary supplements, cosmetics, food and beverages, life sciences, and pharmaceutical industries. The company distributes TRU NIAGEN products direct to consumers through its propriety ecommerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation is headquartered in Los Angeles, California.

Latest CDXC

Latest RGC